Ignite Creation Date:
2024-05-06 @ 2:39 AM
Last Modification Date:
2024-10-26 @ 11:21 AM
Study NCT ID:
NCT02094573
Status:
COMPLETED
Last Update Posted:
2021-03-15
First Post:
2014-03-18
Brief Title:
A Study to Evaluate the Efficacy of Brigatinib AP26113 in Participants With Anaplastic Lymphoma Kinase ALK-Positive Non-small Cell Lung Cancer NSCLC Previously Treated With Crizotinib
Sponsor:
Ariad Pharmaceuticals
Organization:
Takeda
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Carcinoma Non-Small-Cell Lung |
Keywords:
| Name | View |
|---|---|
| Drug Therapy | View |